FDA Final Guidance on Toxicokinetics Studies Available

Home / Community Blog / FDA Final Guidance on Toxicokinetics Studies Available

Community Blog

FDA Final Guidance on Toxicokinetics Studies Available

In a May 10 Federal Register notice, the U.S. Food and Drug Administration (FDA) announced availability of final guidance on the benefits and limitations of the use of microsampling techniques in toxicokinetics studies. Benefits of these techniques include reducing the numbers of animals needed for these studies.
View all FDA guidance documents

Catherine Sprankle
Catherine Sprankle
Communications Specialist for NICEATM